Patents by Inventor Arthur Slutsky

Arthur Slutsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190105316
    Abstract: The present invention provides dry powder formulations comprising nicotine, methods of using the same, and methods for making the same. The dry powder formulations may further comprise excipients, therapeutic agents, and flavor components. The dry powder formulations may be manufactured by dry processes and wet processes.
    Type: Application
    Filed: December 10, 2018
    Publication date: April 11, 2019
    Inventors: Alex Stenzler, Noe Zamel, Arthur Slutsky, Steven Ellis, Steve Han
  • Patent number: 10149844
    Abstract: The present invention provides dry powder formulations comprising nicotine, methods of using the same, and methods for making the same. The dry powder formulations may further comprise excipients, therapeutic agents, and flavor components. The dry powder formulations may be manufactured by dry processes and wet processes.
    Type: Grant
    Filed: March 7, 2017
    Date of Patent: December 11, 2018
    Assignee: Philip Morris Products S.A.
    Inventors: Alex Stenzler, Noe Zamel, Arthur Slutsky, Steven Ellis, Steve Han
  • Publication number: 20180147371
    Abstract: A device for adding a flavor and/or cough suppressant component to an inhaler is described. The device includes a housing having an interior chamber, wherein the housing includes at least one air inlet and at least one air outlet connected to the interior chamber, thereby forming an airflow pathway through the interior chamber, and at least one flavoring and/or cough suppressant component positioned within the interior chamber, wherein the housing is attachable to an exterior surface of an inhaler having at least one air inlet, such that the at least one air outlet of the device aligns with the at least one air inlet of the inhaler to form an airflow path through the device and into the inhaler.
    Type: Application
    Filed: April 13, 2016
    Publication date: May 31, 2018
    Inventors: Alex Stenzler, Steve Han, Arthur Slutsky, Steven Ellis, Noe Zamel, Bildad Nyambura
  • Patent number: 9968125
    Abstract: This invention relates to nicotine microparticles formulations made with the help of a diketopiperazine compound, in particular fumaryl diketopiperazine (FDKP). The invention relates to the various types of microparticles that can be made, in particular nicotine-coated and nicotine-loaded microparticles. The invention further relates to the various methods that can be used in making the microparticles. One particular method involves making FDKP microparticles which are further surface-coated with nicotine. Another particular method involves mixing nicotine with FDKP2? and/or FDKP and then forming microparticles which contain nicotine throughout their volume. The invention also relates to the use of this microparticles in tobacco related therapies, such as tobacco replacement or tobacco withdrawal.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: May 15, 2018
    Assignee: Philip Morris Products S.A.
    Inventors: Alex Stenzler, Noe Zamel, Arthur Slutsky, Steven Ellis
  • Publication number: 20180093051
    Abstract: Described is a dry powder inhaler for inhalation of a dry powder composition. The inhaler includes an external housing that defines an internal passage. The inhaler also includes a mouthpiece, a compartment for holding a dry powder capsule or powder reservoir, and a powder fluidization and deagglomeration apparatus for directing airflow to the dry powder to generate airborne powder particles within the internal passage. When a user inhales through the mouthpiece, a first airflow pattern is generated that has a first airflow resistance, during which the fluidization and deagglomeration apparatus generates airborne dry powder particles within the internal passage. Upon reaching a threshold negative pressure value within the internal passage of the inhaler, a second airflow pattern is generated having a second airflow resistance that is lower than the first airflow resistance, which pulls the airborne dry powder into the user's lungs during the inhalation. Embodiments of elastomeric valves are also described.
    Type: Application
    Filed: April 13, 2016
    Publication date: April 5, 2018
    Inventors: Alex Stenzler, Steve Han, Arthur Slutsky, Steven Ellis, Noe Zamel, William Alston
  • Publication number: 20180093050
    Abstract: A dry powder inhaler dispenses a partial dosage of a powder from a dry powder chamber during a single user inhalation. In certain embodiments, the dry powder chamber is a dry powder capsule that spins in a chamber with a protrusion for limiting the spin of the capsule. In certain embodiments, a capsule slides in a proximal and distal direction for dispensing partial dosages of powder medicament. Air inlets in communication whit the external environment can be included in the inhaler housing for generating a smooth inhalation experience for the user and facilitating operation of partial dosage mechanisms. In other embodiments, a hinged member, sliding member, rotating member, spring tensioned member, pressure actuated valve, dry powder chamber with patterned holes or combinations of these are used as a mechanism for dispensing a partial dosage of powder medicament during a single inhalation.
    Type: Application
    Filed: April 13, 2016
    Publication date: April 5, 2018
    Inventors: Alex Stenzler, Steve Han, Arthur Slutsky, Steven Ellis, Noe Zamel, William Alston
  • Publication number: 20170172996
    Abstract: The present invention provides dry powder formulations comprising nicotine, methods of using the same, and methods for making the same. The dry powder formulations may further comprise excipients, therapeutic agents, and flavor components. The dry powder formulations may be manufactured by dry processes and wet processes.
    Type: Application
    Filed: March 7, 2017
    Publication date: June 22, 2017
    Inventors: Alex Stenzler, Noe Zamel, Arthur Slutsky, Steven Ellis, Steve Han
  • Publication number: 20170071929
    Abstract: A method of reducing nicotine cravings is described. The method includes inhalation of a dry powder formulation containing a dose of nicotine by a subject seeking nicotine cravings reduction. The formulation includes amounts and concentrations of nicotine that are significantly lower than cigarettes or nicotine replacement therapies.
    Type: Application
    Filed: September 16, 2015
    Publication date: March 16, 2017
    Inventors: Alex Stenzler, Noe Zamel, Arthur Slutsky, Steven Ellis
  • Publication number: 20170071248
    Abstract: A method of controlling or electing the harshness of inhaled nicotine powder formulations is described. The method includes the steps of identifying a concentration of nicotine for a subject to inhale to achieve a desired level of harshness per inhalation, identifying the total dose of nicotine to be inhaled by the subject, and providing the subject with an amount of a formulation comprising nicotine particles having the identified concentration of nicotine, such that the total amount of nicotine particles in the formulation equals the total dose of nicotine.
    Type: Application
    Filed: September 16, 2015
    Publication date: March 16, 2017
    Inventors: Alex Stenzler, Noe Zamel, Arthur Slutsky, Steven Ellis
  • Publication number: 20170071856
    Abstract: The present invention provides dry powder formulations comprising nicotine, methods of using the same, and methods for making the same. The dry powder formulations may further comprise excipients, therapeutic agents, and flavor components. The dry powder formulations may be manufactured by dry processes and wet processes.
    Type: Application
    Filed: September 16, 2015
    Publication date: March 16, 2017
    Inventors: Alex Stenzler, Noe Zamel, Arthur Slutsky, Steven Ellis
  • Patent number: 9585835
    Abstract: The present invention provides dry powder formulations comprising nicotine, methods of using the same, and methods for making the same. The dry powder formulations may further comprise excipients, therapeutic agents, and flavor components. The dry powder formulations may be manufactured by dry processes and wet processes.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: March 7, 2017
    Assignee: Sansa Corporation (Barbados) Inc.
    Inventors: Alex Stenzler, Noe Zamel, Arthur Slutsky, Steven Ellis
  • Publication number: 20160198758
    Abstract: This invention relates to nicotine microparticles formulations made with the help of a diketopiperazine compound, in particular fumaryl diketopiperazine (FDKP). The invention relates to the various types of microparticles that can be made, in particular nicotine-coated and nicotine-loaded microparticles. The invention further relates to the various methods that can be used in making the microparticles. One particular method involves making FDKP microparticles which are further surface-coated with nicotine. Another particular method involves mixing nicotine with FDKP2? and/or FDKP and then forming microparticles which contain nicotine throughout their volume. The invention also relates to the use of this microparticles in tobacco related therapies, such as tobacco replacement or tobacco withdrawal.
    Type: Application
    Filed: January 9, 2015
    Publication date: July 14, 2016
    Inventors: Alex Stenzler, Noe Zamel, Arthur Slutsky, Steven Ellis
  • Publication number: 20150283070
    Abstract: A dry powder nicotine formulation suitable for inhalation is described. The formulation includes nicotine particles, wherein the nicotine particles are substantially in the range of about 1-10 micron in size, preferably 2-5 micron in size. The formulation may also include a cough suppressant component having particles in the 5-100 micron size range. The formulation may also include a cough suppressant component having particles in the 10-200 micron size range. The formulation may also include a flavor component having particles in the 10-1000 micron size range.
    Type: Application
    Filed: April 8, 2015
    Publication date: October 8, 2015
    Inventors: Alex Stenzler, Arthur Slutsky, Noe Zamel
  • Patent number: 6462090
    Abstract: Improved formulations for detecting asthma are disclosed. The formulations comprise methacholine or histamine in a dry particulate form wherein the particles are of a respirable size, preferably 2 &mgr;m to 5 &mgr;m. The dry formulations can be inhaled directly from an inhaler and can be used to detect airway narrowing which is diagnostic of asthma.
    Type: Grant
    Filed: April 21, 2000
    Date of Patent: October 8, 2002
    Assignee: Ontario Inc.
    Inventors: Arthur Slutsky, Noe Zamel, Harold Wulffhart
  • Patent number: 6234169
    Abstract: An inhaler for use by an individual to inhale a particulate medicament from a reservoir comprises a chamber having a first end connectable to the reservoir to be in air flow communication therewith, a second end for delivering the medicament to the individual upon inhalation and a conduit defining an air flow path extending between the first end and the second end; and, an orifice in the chamber between the first end and the second end, the orifice utilizing the Coanda Effect when the reservoir is in air flow communication with the chamber and upon inhalation by the individual to draw medicament from the reservoir into the air flow path.
    Type: Grant
    Filed: August 14, 1998
    Date of Patent: May 22, 2001
    Inventors: Lee Bulbrook, Arthur Slutsky, Noe Zamel
  • Patent number: 6102036
    Abstract: A method of assisting a person to withdraw from cigarette induced nicotine dependency, comprising introducing a predetermined dose of a non-pressurized, particulate medicament comprising at least one nicotine formulation suitable for absorption into the bloodstream of the person through the alveoli and small airways of the person's lungs into a breath activated inhaler for use by said person as a cigarette substitute. A breath activated inhaler which may be used in accordance with this method is also disclosed.
    Type: Grant
    Filed: July 30, 1998
    Date of Patent: August 15, 2000
    Assignee: Smoke-Stop
    Inventors: Arthur Slutsky, Noe Zamel